BD introduces landmark cell analyzer featuring breakthrough spectral and real-time cell imaging technologies: Franklin Lakes, ...

Shardul Nautiyal, Mumbai Wednesday, May 14, 2025, 08:00 Hrs [IST] ...

BDCDA cautions on unauthorized channels and infiltration of counterfeit medicines into Karnataka: Nandita Vijayasimha, ...

Barentz to strengthen its pharmaceuticals market presence in Asia Pacific through the envisaged acquisition of Fengli in China: Singapore Wednesday, May 14, 2025, 12:00 Hrs [IST] ...

UK MHRA grants marketing approval for Takeda’s Adzynma to treat congenital thrombotic thrombocytopenic purpura: United Kingdom Wednesday, May 14, 2025, 11:00 Hrs [IST] The Medic ...

91.6% of people treated with the Perjeta-based regimen were alive at ten years versus 89.8% of those treated with Herceptin, chemotherapy, and placebo (hazard ratio [HR]=0.83, 95% CI: 0.69-1.00, ...

Peethaambaran Kunnathoor, Chennai Wednesday, May 14, 2025, 08:00 Hrs [IST] ...

DTAB asks DCGI to take up withdrawal of license for certain FDC antibiotics with SLAs: Gireesh Babu, New Delhi Wednesday, May 14, 2025, 08:00 Hrs [IST] The Drugs Technical Advisor ...

Lifesciences sector maximises adoption of advanced technologies to unlock new possibilities: Nandita Vijayasimha, Bengaluru Wednesday, May 14, 2025, 08:00 Hrs [IST] Life sciences ...

Rein Therapeutics initiates RENEW phase 2 trial of LTI-03 in patients with idiopathic pulmonary fibrosis: Austin, Texas Tuesday, May 13, 2025, 18:00 Hrs [IST] Rein Therapeutics (R ...

Genezen partners with Elly’s Team on development for AAV serotype 9 gene replacement therapy for NEDAMSS: Lexington, Massachusetts Tuesday, May 13, 2025, 17:00 Hrs [IST] Genezen ...

Telangana DCA conducts special raids in pharmacies to verify QR codes on 300 formulation brands: Our Bureau, Chennai Tuesday, May 13, 2025, 13:30 Hrs [IST] The Drugs Control Admin ...